Reply to Mitsuboshi, "Enhancing result reliability by addressing potential confounding factors". [PDF]
Ishigo T +21 more
europepmc +1 more source
Re: Role of confounding factors attributing to the changes in physical activity of students and academic staff of Austrian universities during the COVID-19 lockdown. [PDF]
Ganesh GS.
europepmc +1 more source
Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler +20 more
wiley +1 more source
Utilizing Machine Learning and causal graph approaches to Address Confounding Factors in Health Science Research: A Scoping Review. [PDF]
Hossain A.
europepmc +1 more source
COVID-19 Excess Deaths in Peru's 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State. [PDF]
Chamie JJ, Hibberd JA, Scheim DE.
europepmc +1 more source
Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito +14 more
wiley +1 more source
Importance of Accounting for Confounding Factors when Assessing Cardiovascular Outcomes of COVID-19: A Nationwide Cohort Study. [PDF]
You SH +5 more
europepmc +1 more source
Determining four confounding factors in individual cognitive traits prediction with functional connectivity: an exploratory study. [PDF]
Feng P +6 more
europepmc +1 more source
CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang +6 more
wiley +1 more source
Conformity of spirometric tests with acceptability criteria and assessment of confounding factors in routine clinical practice. [PDF]
Cengiz SK +4 more
europepmc +1 more source

